• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高核度去铁胺衍生物 DFO2 和 DFO2p 作为理想的锆-89 螯合物平台的放射化学、计算和光谱评价。

Radiochemical, Computational, and Spectroscopic Evaluation of High-Denticity Desferrioxamine Derivatives DFO2 and DFO2p toward an Ideal Zirconium-89 Chelate Platform.

机构信息

Department of Chemistry, College of Arts and Science, University of Saskatchewan, Saskatoon, SKS7N 5C9, Canada.

Molecular and Environmental Science Group, Department of Geological Sciences, College of Arts and Science, University of Saskatchewan, Saskatoon, SKS7N 5E2, Canada.

出版信息

Inorg Chem. 2023 Feb 13;62(6):2637-2651. doi: 10.1021/acs.inorgchem.2c03573. Epub 2023 Jan 30.

DOI:10.1021/acs.inorgchem.2c03573
PMID:36716427
Abstract

Desferrioxamine (DFO) has long been considered the gold standard chelator for incorporating [Zr]Zr in radiopharmaceuticals for positron emission tomography (PET) imaging. To improve the stability of DFO with zirconium-89 and to expand its coordination sphere to enable binding of large therapeutic radiometals, we have synthesized the highest denticity DFO derivatives to date: dodecadentate DFO2 and DFO2p. In this study, we describe the synthesis and characterization of a novel DFO-based chelator, DFO2p, which is comprised of two DFO strands connected by an -NO-phenyl linker and therefore contains double the chelating moieties of DFO (potential coordination number up to 12 vs 6). The chelator DFO2p offers an optimized synthesis comprised of only a single reaction step and improves water solubility relative to DFO2, but the shorter linker reduces molecular flexibility. Both DFO2 and DFO2p, each with 6 potential hydroxamate ligands, are able to reach a more energetically favorable 8-coordinate environment for Zr(IV) than DFO. The zirconium(IV) coordination environment of these complexes were evaluated by a combination of density functional theory (DFT) calculations and synchrotron spectroscopy (extended X-ray absorption fine structure), which suggest the inner-coordination sphere of zirconium(IV) to be comprised of the outermost four hydroxamate ligands. These results also confirm a single Zr(IV) in each chelator, and the hydroxide ligands which complete the coordination sphere of Zr(IV)-DFO are absent from Zr(IV)-DFO2 and Zr(IV)-DFO2p. Radiochemical stability studies with zirconium-89 revealed the order of real-world stability to be DFO2 > DFO2p ≫ DFO. The zirconium-89 complexes of these new high-denticity chelators were found to be far more stable than DFO, and the decreased molecular flexibility of DFO2p, relative to DFO2, could explain its decreased stability, relative to DFO2.

摘要

去铁胺(DFO)长期以来一直被认为是将[Zr]Zr 掺入正电子发射断层扫描(PET)成像放射性药物的金标准螯合剂。为了提高 DFO 与锶-89 的稳定性,并扩展其配位场以允许结合大的治疗放射性金属,我们合成了迄今为止最高齿密度的 DFO 衍生物:十二齿 DFO2 和 DFO2p。在这项研究中,我们描述了一种新型 DFO 基螯合剂 DFO2p 的合成和表征,它由两个通过-NO-苯基连接体连接的 DFO 链组成,因此含有两倍的螯合部分(潜在配位数高达 12 比 6)。配体 DFO2p 提供了一个仅由单个反应步骤组成的优化合成,并提高了相对于 DFO2 的水溶性,但较短的连接体降低了分子的灵活性。DFO2 和 DFO2p 都有 6 个潜在的羟肟酸配体,都能够为 Zr(IV) 达到更具能量优势的 8 配位环境,而不是 DFO。通过密度泛函理论(DFT)计算和同步辐射光谱(扩展 X 射线吸收精细结构)相结合,评估了这些配合物的锆(IV)配位环境,这表明锆(IV)的内配位球由最外层的四个羟肟酸配体组成。这些结果还证实了每个螯合剂中只有一个 Zr(IV),并且在 Zr(IV)-DFO 中不存在完成 Zr(IV)配位球的氢氧化物配体。锶-89 的放射化学稳定性研究表明,实际稳定性的顺序为 DFO2 > DFO2p ≫ DFO。这些新的高齿密度螯合剂的锶-89 配合物被发现比 DFO 稳定得多,而 DFO2p 相对于 DFO2 的分子灵活性降低可能解释了其相对 DFO2 的稳定性降低。

相似文献

1
Radiochemical, Computational, and Spectroscopic Evaluation of High-Denticity Desferrioxamine Derivatives DFO2 and DFO2p toward an Ideal Zirconium-89 Chelate Platform.高核度去铁胺衍生物 DFO2 和 DFO2p 作为理想的锆-89 螯合物平台的放射化学、计算和光谱评价。
Inorg Chem. 2023 Feb 13;62(6):2637-2651. doi: 10.1021/acs.inorgchem.2c03573. Epub 2023 Jan 30.
2
A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89.基于去铁胺的高齿螯合剂增强了 89 锶的配位
Inorg Chem. 2020 Aug 17;59(16):11715-11727. doi: 10.1021/acs.inorgchem.0c01629. Epub 2020 Jul 28.
3
Design, Synthesis, and Evaluation of DFO-Em: A Modular Chelator with Octadentate Chelation for Optimal Zirconium-89 Radiochemistry.设计、合成和评价 DFO-Em:一种具有八齿螯合能力的模块化螯合剂,用于优化锆-89 放射性化学。
Inorg Chem. 2022 Dec 26;61(51):20964-20976. doi: 10.1021/acs.inorgchem.2c03442. Epub 2022 Dec 14.
4
Synthesis and evaluation of bifunctional DFO2K: a modular chelator with ideal properties for zirconium-89 chelation.双功能DFO2K的合成与评价:一种具有理想特性用于螯合锆-89的模块化螯合剂。
Dalton Trans. 2024 Dec 3;53(47):18946-18962. doi: 10.1039/d4dt01830c.
5
Structural Characterization of the Solution Chemistry of Zirconium(IV) Desferrioxamine: A Coordination Sphere Completed by Hydroxides.锆(IV)去铁胺溶液化学的结构特征:由氢氧化物完成的配位球。
Inorg Chem. 2020 Dec 7;59(23):17443-17452. doi: 10.1021/acs.inorgchem.0c02725. Epub 2020 Nov 12.
6
DFO-Km: A Modular Chelator as a New Chemical Tool for the Construction of Zirconium-89-Based Radiopharmaceuticals.DFO-Km:一种用于构建基于锝-89 的放射性药物的模块化螯合剂,作为新型化学工具。
Inorg Chem. 2023 Dec 18;62(50):20806-20819. doi: 10.1021/acs.inorgchem.3c02714. Epub 2023 Sep 26.
7
Radiolabelling of the octadentate chelators DFO* and oxoDFO* with zirconium-89 and gallium-68.用 89Zr 和 68Ga 对八齿螯合剂 DFO*和 oxoDFO*进行放射性标记。
J Biol Inorg Chem. 2020 Aug;25(5):789-796. doi: 10.1007/s00775-020-01800-4. Epub 2020 Jul 13.
8
Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for Zr-immuno-PET.用于锆免疫正电子发射断层显像的八齿双功能螯合剂DFO*-pPhe-NCS与临床使用的六齿双功能螯合剂DFO-pPhe-NCS的比较。
Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):286-295. doi: 10.1007/s00259-016-3499-x. Epub 2016 Aug 30.
9
The solution thermodynamic stability of desferrioxamine B (DFO) with Zr(IV).去铁胺 B(DFO)与 Zr(IV)的溶液热力学稳定性。
J Inorg Biochem. 2019 Sep;198:110753. doi: 10.1016/j.jinorgbio.2019.110753. Epub 2019 Jun 15.
10
Cyclic versus Noncyclic Chelating Scaffold for Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression.用于 Zr 标记的 ZEGFR:2377 亲和体生物缀合物的环状与非环状螯合支架,针对表皮生长因子受体过表达。
Mol Pharm. 2018 Jan 2;15(1):175-185. doi: 10.1021/acs.molpharmaceut.7b00787. Epub 2017 Dec 1.

引用本文的文献

1
Isopeptidic Desferrioxamine Analogues: The Role of Hydroxamate Spacing for Chelation of Zr.异肽型去铁胺类似物:异羟肟酸间隔对锆螯合的作用
ChemMedChem. 2025 Mar 15;20(6):e202400890. doi: 10.1002/cmdc.202400890. Epub 2024 Dec 23.
2
A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements.一种一流的双螯合剂治疗诊断剂,设计用于与不同元素的成像-治疗放射性金属对配合使用。
Chem Sci. 2024 Jun 3;15(30):11748-11760. doi: 10.1039/d4sc02851a. eCollection 2024 Jul 31.
3
Preparation of a Zirconium-89 Labeled Clickable DOTA Complex and Its Antibody Conjugate.
锆-89标记的可点击DOTA配合物及其抗体缀合物的制备。
Pharmaceuticals (Basel). 2024 Apr 9;17(4):480. doi: 10.3390/ph17040480.